PATENT CLAIM ANALYSIS

Application Number: 15953716
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "152100"]

Abstract:
Antibodies to human N3pGlu Aβ, compositions comprising such N3pGlu Aβ antibodies, and methods of using such N3pGlu Aβ antibodies for the treatment of a disease characterized by deposition of Aβ including clinical or pre-clinical Alzheimer's disease, Down's syndrome, and clinical or pre-clinical cerebral amyloid angiopathy.

Claim (Index 6):
A method of treating a patient having a condition characterized by deposition of A\u03b2, comprising administering to the patient an effective amount of the antibody of  claim 1 .

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.52941
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15402268', '13810895', '14039113', '12976282', '12754579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7221131001349002
- 35 USC 102 Novelty (BERT): 0.5779963456719969
- Combined Prediction Score: 0.7077014246886099
- Mean Citation Score: 360.161788
- Max Citation Score: 473.79208
- Similarity Product: 410.4016508203936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test